Potential advantages of cell administration on the inflammatory response compared to standard ACE inhibitor treatment in experimental myocardial infarction.

Bone Marrow (BM) progenitor cells can target the site of myocardial injury, contributing to tissue repair by neovascolarization and/or by a possible direct paracrine effect on the inflammatory cascade. Angiotensin Converting Enzyme inhibitors (ACE-I) are effective in reducing mortality and preventing left ventricular (LV) function deterioration after myocardial infarction.
We investigated the short term effects of BM mononuclear cells (BMMNCs) therapy on the pro-inflammatory cytokines (pro-CKs) and on LV remodelling and compared these effects over a standard ACE-I therapy in a rat model of myocardial cryodamage. Forty two adult inbread Fisher-F344 rats were randomized into three groups: untreated (UT; n = 12), pharmacological therapy (ACE-I; n = 14, receiving quinapril), and cellular therapy (BMMNCs; n = 16, receiving BMMNCs infusion). Rats underwent to a standard echocardiogram in the acute setting and 14 days after the damage, before the sacrifice. Pro-CKs analysis (interleukin (IL)1beta, IL-6, tumor necrosis factor (TNF)alpha was performed (multiplex proteome arrays) on blood samples obtained by direct aorta puncture before the sacrifice; a control group of 6 rats was considered as reference.
Concerning the extension of the infarcted area as well as the LV dimensions, no differences were observed among the animal groups; treated rats had lower left atrial diameters and higher indexes of LV function. Pro-Cks were increased in infarcted-UT rats if compared with controls, and significantly reduced by BMMNCs and ACE-I ; TNFalpha inversely correlated with LV fractional shortening.
After myocardial infarction, both BMMNCs and ACE-I reduce the pattern of pro-Ck response, probably contributing to prevent the deterioration of LV function observed in UT rats.
AuthorsMichele M Ciulla, Elisa Montelatici, Stefano Ferrero, Paola Braidotti, Roberta Paliotti, Giuseppe Annoni, Elisa De Camilli, Giuseppe Busca, Luisa Chiappa, Paolo Rebulla, Fabio Magrini, Lorenza Lazzari
JournalJournal of translational medicine (J Transl Med) Vol. 6 Pg. 30 ( 2008) ISSN: 1479-5876 [Electronic] England
PMID18549470 (Publication Type: Comparative Study, Evaluation Studies, Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Tumor Necrosis Factor-alpha
  • Algorithms
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Animals
  • Bone Marrow Transplantation (immunology, physiology)
  • Disease Models, Animal
  • Heart Ventricles (pathology)
  • Inflammation (etiology, therapy)
  • Male
  • Myocardial Infarction (blood, complications, pathology, therapy)
  • Random Allocation
  • Rats
  • Rats, Inbred F344
  • Tumor Necrosis Factor-alpha (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: